Status:
COMPLETED
Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
Ischemic Stroke
Eligibility:
All Genders
65+ years
Brief Summary
The purpose of this study is to determine whether Magnetic Resonance Imaging may predict the risk of Intracerebral Hemorrhage for patients with ischemic stroke who receive indefinite oral anticoagulat...
Detailed Description
OBJECTIVES. To evaluate whether Magnetic Resonance (MR) helps in predicting the risk of Intracranial Hemorrhage (ICH-OA) in patients with ischemic stroke who will receive Oral Anticoagulants (OA) for ...
Eligibility Criteria
Inclusion
- Age \> 65 y
- TIA or ischemic stroke
- The patient will receive indefinitely treatment with oral anticoagulants for the secondary prevention of cardioembolic stroke
- No previous treatment with oral anticoagulants
- Signed consent before performing a Magnetic Resonance
- Long-term follow-up will be possible
Exclusion
- The patient will receive oral anticoagulation as a primary prevention treatment
- The etiology that motivates the onset of oral anticoagulants is not cardioembolism
- Absolute contraindication to receive oral anticoagulants
- Arterial hypertension that is not controlled, hypertensive crisis
- Dementia
- Live-expectancy less than 1 year
- Any social or psychological reason that prevents follow-up
- Contraindication to perform a Magnetic Resonance examination
- Patients who received oral antiacoagulants prior to the current stroke
- The Magnetic Resonance imaging was performed more than 1 month after the onset of treatment with oral anticoagulants
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT02238470
Start Date
April 1 2012
End Date
September 1 2017
Last Update
August 3 2018
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
Arcispedale Santa Maria Nuova IRCCS
Reggio Emilia, Italy
2
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain
3
Fundació Hospital Asil Granollers
Granollers, Barcelona, Spain
4
Hospital de Mataró
Mataró, Barcelona, Spain